Of the 273,000 women who die in childbirth each year, nearly all could be saved with access to C-sections.

In Rwanda, PIH and Harvard researchers complete a major step in redefining psychosocial care.

Lima

World's largest TB research initiative aims to save lives, fight future infections.

PIH-Russia concludes an innovative six-year clinical trial.

Advocating for both cholera vaccination and clean water initiatives in Haiti

Extensively drug-resistant tuberculosis (XDR-TB) is curable with intensive and specialized care conclude two recent studies published in the New England Journal of Medicine (NEJM) and The Lancet. Researchers found that fully 60 percent of the patients enrolled in the studies with XDR-TB were successfully treated and cured.